Navigation Links
Mission Pharmacal Acquires Eletone Cream from Ferndale Healthcare, Inc.
Date:2/3/2012

SAN ANTONIO, Feb. 3, 2012 /PRNewswire/ -- Mission Pharmacal Company recently acquired the prescription barrier cream Eletone® Cream, from Ferndale Healthcare, Inc. of Ferndale, Michigan.  Eletone Cream is a non-steroidal, barrier cream approved by the Food and Drug Administration for the long term treatment of atopic dermatitis, an inflammatory, chronically relapsing, non-contagious and pruritic or itchy skin disorder.

While the addition of Eletone Cream will strengthen Mission's pediatric product offerings, it also enhances the company's targeted expansion in the dermatology market.  To augment and support its sales efforts, Mission has also created a dermatology focused sales team.  In addition to promoting Eletone, this team will be promoting and selling three other dermatology products, Ovace®, Avar®, and Texacort®.  This new team was launched through Alamo Pharma Services, a recently introduced wholly owned subsidiary of Mission Pharmacal, established to provide increased operational and human resources support. 

"Mission Pharmacal's recent advancements in dermatology and pediatrics provide a perfect platform for the promotion of Eletone Cream," states Terry Herring, president of Mission Pharmacal's Commercial Operations.  "This product has an established market share and solid brand identity.  Our intention is to use the Mission dermatology sales team to support this and other dermatology focused products over time."

"From a pure business perspective, the strategic acquisition of Eletone Cream demonstrates Mission's commitment to our core therapeutic areas," notes Neill Walsdorf, Jr., president of Mission Pharmacal Company.  "It adds a product that can be promoted by both our pediatric and dermatology sales teams."

About Mission Pharmacal

Mission Pharmacal is a privately held pharmaceutical company based in San Antonio, Texas.  For more than 65 years, the company has been committed to meeting the unique healthcare needs of women throughout all stages of life, pediatric patients, and those persons dealing with urologic and dermatologic conditions.  The company has a proven track record of identifying unmet healthcare needs and developing both innovative prescription and over-the-counter products to meet these needs.  Using only the purest ingredients, Mission Pharmacal provides physicians and consumers with the highest quality pharmaceutical and dietary supplement products on the market today.  Mission Pharmacal is a proud national supporter of the March of Dimes Foundation, whose mission is to improve the health of babies by preventing birth defects, premature birth, and infant mortality.  For more information about the company, visit www.missionpharmacal.com.

About Ferndale Healthcare, Inc.

Ferndale Healthcare™ specializes in markets encompassing disease states ranging from benign anorectal disorders to skin conditions. Their mission is to provide high-quality, value-added products that help patients get back to what matters most in their lives—living well.  Ferndale Healthcare offers a wide array of effective products including both over-the-counter and prescription formulations.  They are proud that so many of their products are leaders in there respective categories and that they continue to maintain that leadership position. For more information about the company, visit www.ferndalehealthcare.com.


'/>"/>
SOURCE Mission Pharmacal
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Indevus Announces Submission of New Drug Application
2. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
3. BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
4. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
5. Game Commission Announces EHD Confirmed in Fayette County
6. Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing
7. PARIs eFlow Included in Gileads NDA Submission for Aztreonam Lysine for Inhalation
8. Wyeths TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
9. Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission
10. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
11. FDA to Extend Review of Data Quality Submission for Genasense(R) in Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... , April 29, 2016 ... glyco-biology expertise, today announces the appointment of Dr. ... Dr. Zurlo is an oncologist with many years clinical ... and biotechnology industries. His last role was at Mologen ... of the Executive Board. Previously Dr. Zurlo held various ...
(Date:4/28/2016)... YORK , April 28, 2016  While ... notably complement the company,s valve repair and stent ... move also places Abbott more firmly into patient ... of the fastest growing device areas, with double-digit ... its recent report,  Advanced Remote Patient Monitoring ...
(Date:4/28/2016)... Dr. ... und Stephen Schmidt werden Teil ... ein führender Anbieter cloudbasierter Softwarelösungen für den ... neue Führungskräfte zum Team Sicherheit und Pharmakovigilanz ... Erfahrungen mitbringen.  Dies wird die Geschäftseinheit Sicherheit ...
Breaking Medicine Technology:
(Date:4/29/2016)... Beverly Hills, CA (PRWEB) , ... April 29, 2016 , ... ... distributor of devices and products for the head and neck/ear, nose and throat specialty, ... Safety Device , The KOTLER NASAL AIRWAY™ is a newly patented safety ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... a growth round of funding led by Eastside Partners, with participation from existing ... rapidly growing customer base and accelerate its technology and product roadmap. ...
(Date:4/29/2016)... ... April 29, 2016 , ... Regenerative Medicine Solutions (RMS) scored ... satisfaction survey, earning them second place for Tampa’s Best Places to Work. They were ... “This is a great accomplishment for our team,” says RMS Human Resources Manager Irene ...
(Date:4/29/2016)... CA (PRWEB) , ... April 29, 2016 , ... The ... L. Frederick, Dr. Sanaz Ghazal, and Dr. Daniel A. Potter -- are proud of ... for Assisted Reproductive Technology (SART). In April, SART published the latest verified ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, Inc. recently sent representatives ... Petbiotics ™, as they fondly call them. As animal lovers, they were ... their non-profit organizations. Animal rescues across the nation face huge hurdles rescuing animals ...
Breaking Medicine News(10 mins):